Nitish Bhatia , Benu George , Daljeet Masih , Mohd. Masih Uzzaman Khan , Priya Malik
{"title":"自身免疫性疾病中PAMP和DAMP驱动NETosis激活的机制","authors":"Nitish Bhatia , Benu George , Daljeet Masih , Mohd. Masih Uzzaman Khan , Priya Malik","doi":"10.1016/j.intimp.2025.115149","DOIUrl":null,"url":null,"abstract":"<div><div>Neutrophil extracellular trap (NET) formation, commonly known as NETosis, is an innate immune response where neutrophils release chromatin structures embedded with antimicrobial proteins to combat pathogens. While NETosis plays a critical role in host defense, dysregulated NETosis is increasingly implicated in the pathogenesis of autoimmune disorders, including systemic lupus erythematosus, rheumatoid arthritis, and antiphospholipid syndrome. Central to this process are pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), which act as potent triggers for NETosis. PAMPs, derived from microbial components, and DAMPs, released from damaged host tissues, engage pattern recognition receptors (PRRs) to activate intracellular signaling cascades leading to NET formation. Emerging evidence highlights the dual role of NETosis in modulating immune responses: while it facilitates microbial clearance, excessive or prolonged NETosis exacerbates autoimmunity by exposing self-antigens and perpetuating inflammation. This review explores the mechanistic insights into PAMP- and DAMP-driven NETosis, their interplay in autoimmune pathophysiology, and their potential as therapeutic targets to mitigate disease progression.</div></div>","PeriodicalId":13859,"journal":{"name":"International immunopharmacology","volume":"162 ","pages":"Article 115149"},"PeriodicalIF":4.7000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mechanistic insights into PAMP and DAMP driven activation of NETosis in autoimmune disorders\",\"authors\":\"Nitish Bhatia , Benu George , Daljeet Masih , Mohd. Masih Uzzaman Khan , Priya Malik\",\"doi\":\"10.1016/j.intimp.2025.115149\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Neutrophil extracellular trap (NET) formation, commonly known as NETosis, is an innate immune response where neutrophils release chromatin structures embedded with antimicrobial proteins to combat pathogens. While NETosis plays a critical role in host defense, dysregulated NETosis is increasingly implicated in the pathogenesis of autoimmune disorders, including systemic lupus erythematosus, rheumatoid arthritis, and antiphospholipid syndrome. Central to this process are pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), which act as potent triggers for NETosis. PAMPs, derived from microbial components, and DAMPs, released from damaged host tissues, engage pattern recognition receptors (PRRs) to activate intracellular signaling cascades leading to NET formation. Emerging evidence highlights the dual role of NETosis in modulating immune responses: while it facilitates microbial clearance, excessive or prolonged NETosis exacerbates autoimmunity by exposing self-antigens and perpetuating inflammation. This review explores the mechanistic insights into PAMP- and DAMP-driven NETosis, their interplay in autoimmune pathophysiology, and their potential as therapeutic targets to mitigate disease progression.</div></div>\",\"PeriodicalId\":13859,\"journal\":{\"name\":\"International immunopharmacology\",\"volume\":\"162 \",\"pages\":\"Article 115149\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International immunopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1567576925011397\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International immunopharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1567576925011397","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Mechanistic insights into PAMP and DAMP driven activation of NETosis in autoimmune disorders
Neutrophil extracellular trap (NET) formation, commonly known as NETosis, is an innate immune response where neutrophils release chromatin structures embedded with antimicrobial proteins to combat pathogens. While NETosis plays a critical role in host defense, dysregulated NETosis is increasingly implicated in the pathogenesis of autoimmune disorders, including systemic lupus erythematosus, rheumatoid arthritis, and antiphospholipid syndrome. Central to this process are pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), which act as potent triggers for NETosis. PAMPs, derived from microbial components, and DAMPs, released from damaged host tissues, engage pattern recognition receptors (PRRs) to activate intracellular signaling cascades leading to NET formation. Emerging evidence highlights the dual role of NETosis in modulating immune responses: while it facilitates microbial clearance, excessive or prolonged NETosis exacerbates autoimmunity by exposing self-antigens and perpetuating inflammation. This review explores the mechanistic insights into PAMP- and DAMP-driven NETosis, their interplay in autoimmune pathophysiology, and their potential as therapeutic targets to mitigate disease progression.
期刊介绍:
International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.
The subject material appropriate for submission includes:
• Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.
• Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.
• Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.
• Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.
• Agents that activate genes or modify transcription and translation within the immune response.
• Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.
• Production, function and regulation of cytokines and their receptors.
• Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.